MAOIs Atomoxetine

ATOMOXETINE MAOIs Risk of severe hypertensive reactions Additive inhibition of norepinephrine reuptake Avoid co-administration. MAOIs should not be started for at least 2 weeks after stopping atomoxetine conversely, atomoxetine should not be started for at least 2 weeks after stopping MAOI... [Pg.275]

MAOIs Do not take atomoxetine with an MAOl or within 2 weeks after discontinuing an MAOl. Do not initiate treatment with an MAOl within 2 weeks after discontinuing atomoxetine. With other drugs that affect brain monoamine concentrations, there... [Pg.1173]

Drugs that may interact with atomoxetine include albuterol, CYP2D6 inhibitors, MAOIs, and pressor agents. [Pg.1175]

Atomoxetine is contraindicated in patients with narrow-angle glaucoma or in combination with an MAOI. [Pg.191]

The manufacturer contraindicates the concurrent use of atomoxetine and MAOIs on theoreticai grounds. Atomoxetine is predicted to have additive effects with pressor drugs and other sympathomimetics and has been seen to potentiate the increase in heart rate and biood pressure seen with intravenous salbutamol. However, no increase in cardiovascuiar effects was seen when atomoxetine was given with methyiphenidate. [Pg.203]

The manufacturer contraindicates the concurrent use of atomoxetine with MAOIs, or within 2 weeks of stopping an MAOI, because other drugs that affect brain monoamine levels have caused serious reactions (similar to the neuroleptic malignant syndrome) when taken with MAOIs. ... [Pg.203]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...